NovaBioAssays

NovaBioAssays is a privately held, revenue-generating CRO providing specialized bioanalytical and characterization services to the biopharmaceutical industry. Leveraging advanced mass spectrometry and other analytical technologies, the company supports clients across diverse therapeutic areas from discovery through regulatory filing. With a team of industry veterans and state-of-the-art facilities, it serves a global clientele that includes top-tier biopharma companies, biotechs, and academic institutions, positioning itself as a partner for complex analytical challenges in modern drug development.

Advanced mass spectrometry (LC-MS/MS, LC-HRMS, HDX-MS), liquid chromatography, and ligand-binding assays for bioanalysis and characterization of proteins, antibodies, ADCs, oligonucleotides, small molecules, and gene therapy vectors.

Operates in a crowded CRO market, competing against large, full-service organizations (e.g., LabCorp, IQVIA) and numerous specialized boutique labs. Differentiates through deep expertise in complex modalities, a partnership-oriented approach, and a team with direct big pharma R&D experience.